Significant Correlation between Ankle-Brachial Index and Vascular Access Failure in Hemodialysis Patients

被引:36
作者
Chen, Szu-Chia [1 ,2 ]
Chang, Jer-Ming [1 ,2 ,4 ]
Hwang, Shang-Jyh [2 ,4 ]
Tsai, Jer-Chia [2 ,4 ]
Wang, Chuan-Sheng [1 ]
Mai, Hsiu-Chin [1 ]
Lin, Feng-Hsien [1 ]
Su, Ho-Ming [1 ,3 ,4 ]
Chen, Hung-Chun [2 ,4 ]
机构
[1] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung 812, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung 812, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung 812, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung 812, Taiwan
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 4卷 / 01期
关键词
PERIPHERAL ARTERIAL-DISEASE; BLOOD-PRESSURE INDEX; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; ARTERIOVENOUS-FISTULAS; OCCLUSIVE DISEASE; RENAL-FAILURE; MORTALITY; ATHEROSCLEROSIS; IMPACT;
D O I
10.2215/CJN.03080608
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Vascular access failure (VAF) is associated with increased morbidity and mortality in hemodialysis patients. The most common cause of VAF is stenosis at the arteriovenous anastomosis because of abnormal neointimal proliferation and extracellular matrix deposition. These two changes are also observed in the classic atheroma, which means atherosclerotic lesions and venous stenosis in VAF may share some similar pathogenic mechanisms. The ankle-brachial index (ABD is a reliable marker for atherosclerosis. The aim of this study was to evaluate the relationship between ABI <0.9 and VAF. Design, setting, participants, & measurements: All routine hemodialysis patients in one regional hospital were included except for six patients refusing ABI examinations and four patients with atrial fibrillation. Finally, 225 patients formed our study group. The study subjects were observed from arteriovenous access creation until the first episode of VAF. The mean observation period was 42.2 +/- 42.8 mo. The relative VAF risk was analyzed by Cox-regression methods with adjustments for demographic and comorbid conditions. Results: VAF episodes were recorded in 111 patients. In multivariate analysis, ABI <0.9 (hazard ratio, 1.893; P = 0.039), vascular access type of arteriovenous graft (P = 0.004), and serum triglyceride level (P = 0.043) were positively associated with VAF, and serum parathyroid hormone level (P = 0.043) was negatively associated with VAF. Conclusions: Our findings show that ABI <0.9 is significantly correlated with increased VAF. Screening hemodialysis patients by means of ABI may help to identify a high-risk group for VAF.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
[1]  
Ascher Enrico, 2004, Semin Vasc Surg, V17, P3, DOI 10.1053/j.semvascsurg.2003.11.009
[2]   Critical issues in peripheral arterial disease detection and management - A call to action [J].
Belch, JJF ;
Topol, EJ ;
Agnelli, G ;
Bertrand, M ;
Califf, RM ;
Clement, DL ;
Creager, MA ;
Easton, JD ;
Gavin, JR ;
Greenland, P ;
Hankey, G ;
Hanrath, P ;
Hirsch, AT ;
Meyer, J ;
Smith, SC ;
Sullivan, F ;
Weber, MA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (08) :884-892
[3]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[4]   Time to symptomatic vascular stenosis at different locations in patients with arteriovenous grafts [J].
Bozof, Ryan ;
Kats, Mark ;
Barker, Jill ;
Allon, Michael .
SEMINARS IN DIALYSIS, 2008, 21 (03) :285-288
[5]   Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model [J].
Chen, CY ;
Lumsden, AB ;
Ofenloch, JC ;
Noe, B ;
Campbell, EJ ;
Stratford, PW ;
Yianni, YP ;
Taylor, AS ;
Hanson, SR .
ANNALS OF VASCULAR SURGERY, 1997, 11 (01) :74-79
[6]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[7]   CANADIAN HEMODIALYSIS MORBIDITY STUDY [J].
CHURCHILL, DN ;
TAYLOR, DW ;
COOK, RJ ;
LAPLANTE, P ;
BARRE, P ;
CARTIER, P ;
FAY, WP ;
GOLDSTEIN, MB ;
JINDAL, K ;
MANDIN, H ;
MCKENZIE, JK ;
MUIRHEAD, N ;
PARFREY, PS ;
POSEN, GA ;
SLAUGHTER, D ;
ULAN, RA ;
WERB, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :214-234
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   A now device for automatic measurements of arterial stiffness and ankle-brachial index [J].
Cortez-Cooper, MY ;
Supak, JA ;
Tanaka, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (12) :1519-1522
[10]   Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation [J].
Deighan, CJ ;
Caslake, MJ ;
McConnell, M ;
Boulton-Jones, JM ;
Packard, CJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :852-862